| Literature DB >> 34318684 |
Hamid Mostafavi Abdolmaleky1,2, Jin-Rong Zhou2, Sam Thiagalingam1,3,4.
Abstract
During the last two decades, diverse epigenetic modifications including DNA methylation, histone modifications, RNA editing and miRNA dysregulation have been associated with psychiatric disorders. A few years ago, in a review we outlined the most common epigenetic alterations in major psychiatric disorders (e.g., aberrant DNA methylation of DTNBP1, HTR2A, RELN, MB-COMT and PPP3CC, and increased expression of miR-34a and miR-181b). Recent follow-up studies have uncovered other DNA methylation aberrations affecting several genes in mental disorders, in addition to dysregulation of many miRNAs. Here, we provide an update on new epigenetic findings and highlight potential origin of the diversity and inconsistencies, focusing on drug effects, tissue/cell specificity of epigenetic landscape and discuss shortcomings of the current diagnostic criteria in mental disorders.Entities:
Keywords: DTNBP1; HTR2A; HTR4; LINE-1; MB-COMT; RELN; miR-137; miR-181b; miR-34a; miR-451a
Mesh:
Substances:
Year: 2021 PMID: 34318684 PMCID: PMC8738978 DOI: 10.2217/epi-2021-0074
Source DB: PubMed Journal: Epigenomics ISSN: 1750-192X Impact factor: 4.357